Harrow sells eye care medicines and compounded eye formulations to eyecare doctors and their patients. It last closed at $29.52 on Nov 17, up 1.48% on the day. HROW last reported earnings on Mon, Nov 9, 2026.
Only 1 firm rated HROW in the past 90 days, not enough for a consensus
Average 12-month target
$45.00
▲ 52.4% upside
Based on 1 analyst who set a price target on HROW in the past 90 days. The average target is $45.00, with a high of $45.00 and a low of $45.00, compared with the last close of $29.52.
Low $45.00Avg $45.00High $45.00
Blue marker: last close $29.52
Highest target$45.00
Average target$45.00
Lowest target$45.00
Latest rating changes
Leerink PartnersInitiated
Sep 9Buy$45
BTIGReiterated
Jul 21Buy$63
Date
Firm
Action
Rating
Price target
Sep 9
Leerink Partners
Initiated
Buy
$45
Jul 21
BTIG
Reiterated
Buy
$63
Loading…
Technical Analysis
HROW · as of the Nov 17 close · updated after every close
Moving sideways
The stock sits between its 20 and 50 day averages. It is 27% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 51). The nearest support is the Pivot at $29.32, and the nearest resistance the Pivot R1 at $29.88.
Short trendNeutral
Long trendBearish
MomentumImproving
StretchNormal
VolatilityHigh, 5.9%/day
Key levels
$54.8552 week high+85.8%
$37.37200 day average+26.6%
$35.59100 day average+20.6%
$30.4250 day average+3.0%
$30.28Swing high (Oct 29)+2.6%
$29.88Pivot R1+1.2%
$29.52Last close
$29.32Pivot−0.7%
$28.95Pivot S1−1.9%
$28.6620 day average−2.9%
$27.14Swing low (Oct 23)−8.1%
$25.7652 week low−12.7%
Indicators
RSI (14)
51.03
Middle of its range
Neutral
MACD
-0.31
Above its signal line
Bullish
Stochastic
48.2
Middle of its range
Neutral
ADX (14)
33.3
Trending up
Williams %R
-52.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
49.6
Oversold below −100, overbought above 100
Neutral
Rate of change
+3.4%
Change over 10 sessions
Bullish
ATR (14)
$1.74
Typical daily range, 5.9% of price
MA 10Above
MA 20Above
MA 50Below
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNormal
VolatilityNormal, 14.0%/day
Key levels
$54.8552 week high+85.8%
$37.37200 day average+26.6%
$35.59100 day average+20.6%
$30.4250 day average+3.0%
$30.28Swing high (Oct 29)+2.6%
$29.88Pivot R1+1.2%
$29.52Last close
$29.32Pivot−0.7%
$28.95Pivot S1−1.9%
$28.6620 day average−2.9%
$27.14Swing low (Oct 23)−8.1%
$25.7652 week low−12.7%
Indicators
RSI (14)
41.10
Middle of its range
Neutral
MACD
-3.00
Below its signal line
Bearish
Stochastic
18.0
Near the bottom of its range
Oversold
ADX (14)
16.8
No clear trend
Williams %R
-77.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
-71.7
Oversold below −100, overbought above 100
Neutral
Rate of change
−14.4%
Change over 10 sessions
Bearish
ATR (14)
$4.13
Typical daily range, 14.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for HROW
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how HROW did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow HROW usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How HROW has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2007.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether HROW is in one of them and how their past HROW trades turned out.
Harrow sells eye care medicines, mainly in the United States and Canada. Its branded portfolio includes eye drops and injections for conditions such as dry eye disease, pain after cataract surgery, bacterial eye infections, allergic itching and wet macular degeneration. The company also runs a compounding pharmacy business that supplies custom formulations. Its customers are eyecare doctors, surgeons and their patients. Harrow is based in Nashville, Tennessee.